Bleichroeder LP - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 34 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bleichroeder LP ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$318,493
-18.1%
810,4160.0%0.07%
-20.0%
Q4 2022$389,000
-71.2%
810,4160.0%0.08%
-69.9%
Q3 2022$1,353,000
-41.2%
810,4160.0%0.28%
-40.6%
Q2 2022$2,302,000
-43.5%
810,4160.0%0.48%
-34.3%
Q1 2022$4,076,000
-49.6%
810,4160.0%0.72%
-42.7%
Q4 2021$8,080,000
-23.3%
810,4160.0%1.26%
-26.3%
Q3 2021$10,535,000
-7.6%
810,4160.0%1.71%
-0.5%
Q2 2021$11,403,000
-12.9%
810,4160.0%1.72%
+54.0%
Q1 2021$13,088,000810,4161.12%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$2,778,0004.72%
TRB Advisors LP 570,000$952,0000.94%
Bleichroeder LP 810,416$1,353,0000.28%
LAKE STREET ADVISORS GROUP, LLC 739,136$1,234,0000.09%
Ikarian Capital, LLC 237,553$397,0000.08%
Oasis Management Co Ltd. 225,000$376,0000.06%
Aperture Investors, LLC 192,794$322,0000.05%
MSD Partners, L.P. 388,691$649,0000.05%
Proficio Capital Partners LLC 110,559$185,0000.03%
Baupost Group 1,123,108$1,876,0000.03%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders